64799 Federal Register

Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices
Docket #
(FHFAID)
Member
City
13260 ............
55342 ............
55117 ............
55245 ............
55213 ............
55118 ............
4347 ..............
14623 ............
16274 ............
1925 ..............
16193 ............
1528 ..............
16484 ............
16506 ............
921 ................
55069 ............
3903 ..............
10647 ............
55077 ............
3790 ..............
15949 ............
9491 ..............
13484 ............
15713 ............
Bank of Eastern Oregon ......................................................................................
Great Western Insurance Company ....................................................................
Transportation Alliance Bank, Inc. .......................................................................
Granite Federal Credit Union ...............................................................................
Cyprus Credit Union .............................................................................................
Great Northwest Credit Union ..............................................................................
Riverview Community Bank .................................................................................
The Bank of Washington .....................................................................................
Fife Commercial Bank ..........................................................................................
Olympia FS & LA .................................................................................................
TwinStar Credit Union ..........................................................................................
First FS & LA of Port Angeles .............................................................................
Seattle Savings Bank ...........................................................................................
Our Community Federal Credit Union .................................................................
Yakima FS & LA ..................................................................................................
Solarity Credit Union ............................................................................................
Buffalo Federal Bank ...........................................................................................
Hilltop National Bank ............................................................................................
Wyhy Credit Union ...............................................................................................
Big Horn Federal Savings Bank ..........................................................................
Oregon Trail Bank ................................................................................................
Rocky Mountain Bank ..........................................................................................
RSNB Bank ..........................................................................................................
Pinnacle Bank—Wyoming ....................................................................................
Heppner ................................................
Ogden ...................................................
Ogden ...................................................
Salt Lake City .......................................
West Jordan ..........................................
Aberdeen ..............................................
Camas ...................................................
Edmonds ...............................................
Fife ........................................................
Olympia .................................................
Olympia .................................................
Port Angeles .........................................
Seattle ...................................................
Shelton ..................................................
Yakima ..................................................
Yakima ..................................................
Buffalo ...................................................
Casper ..................................................
Cheyenne ..............................................
Greybull .................................................
Guernsey ..............................................
Rock Springs ........................................
Rock Springs ........................................
Torrington ..............................................
II. Public Comments
Dated: October 27, 2014.
Melvin L. Watt,
Director, Federal Housing Finance Agency.
[FR Doc. 2014–25970 Filed 10–30–14; 8:45 am]
BILLING CODE 8070–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
VerDate Sep<11>2014
18:51 Oct 30, 2014
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Bijan Ahvazi, Ph.D., National
Institutes of Health: Based on the report
of an investigation conducted by the
National Institutes of Health (NIH) and
additional analysis by ORI in its
oversight review, ORI found that Dr.
Bijan Ahvazi, former Director of the
Laboratory of X-ray Crystallography,
National Institute of Arthritis and
Musculoskeletal and Skin Diseases
(NIAMS), NIH, engaged in research
misconduct in research supported by
the Intramural Program at NIAMS, NIH.
ORI found that Respondent engaged
in research misconduct by falsifying
data related to or in the following
published papers:
1. Ahvazi, B., Boeshans, K.M., Idler,
W., Baxa, U., & Steinert, P.M.
‘‘Structural basis for the coordinated
regulation of transglutaminase 3 by
guanine nucleotides and calcium/
magnesium.’’ J. Biol. Chem.
279(8):7180–92, 2004 Feb 20
(withdrawn) (hereinafter ‘‘JBC 2004a’’)
2. Ahvazi, B., Boeshans, K.M., &
Steinert, P.M. ‘‘Crystal structure of
transglutaminase 3 in complex with
BMP: Structural basis for nucleotide
specificity.’’ J. Biol. Chem. 279:26716–
25, 2004 (withdrawn) (hereinafter ‘‘JBC
2004b’’)
3. Ahvazi, B., Boeshans, K.M., Idler,
W.,& Cooper, A.J.L. ‘‘Crystal structure of
transglutaminase 3-cystamine complex:
Binding of two cystamines to the
nucleotide-binding pocket. M6:06060,
SUMMARY:
To encourage the submission of
public comments on the community
support performance of Bank members,
on or before November 17, 2014, each
Bank will notify its Advisory Council,
nonprofit housing developers,
community groups and other interested
parties in its district of the members of
the Bank selected for this review cycle.
12 CFR 1290.2(b)(2)(ii). In reviewing a
member for community support
compliance, FHFA will consider any
public comments it has received
concerning the member. 12 CFR
1290.2(d). To ensure consideration by
FHFA, comments concerning the
community support performance of
members selected for this review cycle
must be submitted to FHFA, either by
electronic mail to
hmgcommunitysupportprogram@
fhfa.gov, or by fax to 202–649–4130, on
or before December 15, 2014.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
64799
Jkt 235001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
State
OR
UT
UT
UT
UT
WA
WA
WA
WA
WA
WA
WA
WA
WA
WA
WA
WY
WY
WY
WY
WY
WY
WY
WY
Submitted to J. Biol. Chem., 2006
(rejected) (hereinafter ‘‘JBC 2006’’).
Specifically, ORI finds that
Respondent:
1. Falsely labeled Figure 3A in JBC
2004b representing an isothermal
calorimetric titration (ITC) experiment
using guanine monophosphate (GMP)
and transglutaminase 3 (TGase 3) when
the figure was actually a relabeled
version of an unrelated experiment that
Respondent previously published as
Figure 1A in JBC 2004a.
2. falsified Figure 4B, Figure 4C, and
Figure 6D in JBC 2004b and Figure 5E
in JBC 2006, by altering the original data
in the following ways to represent the
desired experiment:
a. Falsified Figure 4B in JBC 2004b, by
adding multiple data points to
titration curves for four different
concentrations of TGase 3 bound by
different concentrations of tagged
GTPgS and deleting two (2) outlying
data points from one of the curves
b. falsified Figure 4C in JBC 2004 b,
representing a competition assay for
the release of tagged GTPgS bound
to TGase 3, by (1) falsely claiming
that the release of the tagged
nucleotide occurred with the
addition of untagged GMP, when
the result was from an assay using
untagged GDP, (2) adding
additional data points onto the
titration curves, and (3) altering the
scale of the abscissa
c. falsified Figure 6D in JBC 2004b, by
using the false Figure 4B to also
represent an additional competition
experiment using unmodified
nucleotide analog compounds and
E:\FR\FM\31OCN1.SGM
31OCN1
64800
Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
ATP; specifically, Respondent (1)
falsified the units and labels of the
axes, (2) falsified the labels of the
curves, and (3) vertically inverted
the curves
d. falsified Figure 5E in the JBC 2006
manuscript, representing a
competition experiment for the
release of tagged GTPgS bound to
TGase 3 with the addition of
cystamine, when the actual
experiment was a competition
experiment with the addition of
untagged nucleotides.
Dr. Ahvazi has entered into a
Voluntary Settlement Agreement
(Agreement) and has voluntarily agreed
for a period of two (2) years, beginning
on October 7, 2014:
(1) To have his U.S. Public Health
Service (PHS) research supervised and
to notify any employer(s)/institution(s)
at which he may participate in PHS
funded projects of the terms of his
supervision; Respondent agrees that
prior to the submission of an
application for PHS support for a
research project on which the
Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity on PHS-supported
research, Respondent shall ensure that a
plan for supervision of Respondent’s
duties is submitted to ORI for approval;
the supervision plan must be designed
to ensure the scientific integrity of
Respondent’s research; Respondent
agrees that he shall not participate in
any PHS-supported research until such
a supervision plan is submitted to and
approved by ORI; Respondent agrees to
maintain responsibility for compliance
with the agreed upon supervision plan;
(2) that any institution employing him
to work on PHS-supported projects shall
submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract; and
(3) to exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant.
FOR FURTHER INFORMATION CONTACT:
Acting Director, Office of Research
Integrity, 1101 Wootton Parkway, Suite
VerDate Sep<11>2014
18:51 Oct 30, 2014
Jkt 235001
750, Rockville, MD 20852, (240) 453–
8200.
Donald Wright,
Acting Director, Office of Research Integrity.
[FR Doc. 2014–25887 Filed 10–30–14; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Intent To Award Ebola
Response Outbreak Funding to
Eligible Ministries of Health and Their
Bona Fide Agents
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides public
announcement of CDC’s intent to award
Ebola appropriations to select Ministries
of Health and their bona fide agents for
response to the Ebola outbreak funding.
This award was proposed in Fiscal Year
(FY) 2015 under funding opportunity
announcement GH14–1418, ‘‘Protecting
and Strengthening Public Health
Impact, Systems, Capacity, and
Security.’’
This notice replaces the Notice of
Intent to award Ebola Response
outbreak funding to eligible Ministries
of Health and their bona fide agents
which was published on October 22,
2014 (79 FR 63126, October 22, 2014).
CDC is correcting the application date,
award dates, amount of funding
available, and one of the points of
contact.
SUMMARY:
Catalogue of Federal Domestic Assistance
Number (CFDA): 93.318.
Authority: Public Health Service 301(a)
and 307 as amended [42 U.S.C 241 and 242l].
Multiple awards may be awarded to
grantees totaling $300,000 to $1,500,000
per award for the Ebola response
outbreak.
Funding is appropriated under the
Continuing Appropriations Resolution,
2015, Public Law 113–164, 128 Stat.
1867 (2014).
DATES: Anticipated award date is 12/11/
2014.
Application Due Date: 12/1/2014.
Project Number is CDC–RFA–GH14–
1418.
CDC has waived the
Grants.gov electronic submission
process for this requirement. Recipients
are hereby authorized to submit a paper
copy application for (CDC–RFA–GH14–
1418) via Express Mail (i.e. FedEx, UPS,
ADDRESSES:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
or DHL) and send the application via
email. Mailed applications must be
address to Dionne Bounds, Centers for
Disease Control and Prevention, 2920
Brandywine Road, Atlanta, GA 30341,
telephone (770) 488–2082, or email at
DBounds@cdc.gov. The application
must include a detailed line-item budget
and justification to support the Ebola
activities from December 11, 2014 to
September 29, 2015. Please download
the following to complete the
application package: http://
apply07.grants.gov/apply/forms/
sample/SF424_2_1-V2.1.pdf—
Application Package; http://
www.cdc.gov/od/pgo/funding/docs/
CertificationsForm.pdf—Certifications;
http://www.cdc.gov/od/pgo/funding/
grants/Budget_Preparation_Guidelines_
8-2-12.docx—CDC–PGO Budget
Guidelines; http://apply07.grants.gov/
apply/forms/sample/SF424A-V1.0.pdf—
SF–424A Budget Information.
All applications must be submitted to
and received by the Grants Management
Officer (GMO) no later than 11:59 p.m.
EST on December 1, 2014 and please
provide the GMO a PDF version of the
application by email to the following
email address: ogsghebolaresponse@
cdc.gov subject line: CDC–RFA–GH14–
1418.
Applicants will be provided with the
Funding Opportunity Announcement
(FOA) and additional application
submission guidance via email
notification. Applicants may contact the
POCs listed with questions regarding
the application process.
FOR FURTHER INFORMATION CONTACT:
For programmatic or technical
assistance: Kawi Mailutha, Project
Officer, Department of Health and
Human Services, Centers for Disease
Control and Prevention, 1600 Clifton
Rd. MS E–29, Atlanta, GA 30333,
Telephone: 404–639–8093, E-Mail:
KMailutha@cdc.gov.
For financial, awards management, or
budget assistance: Dionne Bounds,
Grants Management Officer, Centers for
Disease Control and Prevention, 2920
Brandywine Road, Atlanta, GA 30341,
Telephone (770) 488–2082, Email:
DBounds@cdc.gov.
SUPPLEMENTARY INFORMATION: The
purpose of this notice is to solicit
applications from eligible Ministries of
Health and their bona fide agents to
quickly arrest the spread of the Ebola
virus in West Africa and contain the
disease as quickly as possible. The
funding will support the impacted
countries and the surrounding countries
to combat this health crisis. This
funding will target the following
countries: Liberia, Sierra Leone, Guinea,
E:\FR\FM\31OCN1.SGM
31OCN1